Eltoprazine Added to Antipsychotics for Thinking Skills in Schizophrenia
About this title
Read the official source — NCT01266174Researchers compared Eltoprazine and placebo to find out how the approaches affected memory, attention and other thinking skills in adults with schizophrenia.
Understand this study
What did researchers investigate?
Researchers compared Eltoprazine and placebo to find out how the approaches affected memory, attention and other thinking skills in adults with schizophrenia.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Los Angeles and 5 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 31
- Sponsor
- Amarantus BioScience Holdings, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01266174
- Official title
Show the full official title
Randomized, Double-blind, Parallel Trial Comparing the Effects of Eltoprazine (Adjunct to Anti-psychotics) With Placebo in Adults With Schizophrenia, in Improving One or More Dimensions of Cognitive Impairment Associated With Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Los Angeles · Chicago · Catonsville
3 more locations
- Boston
- New York
- Durham
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Eltoprazine and placebo to find out how the approaches affected memory, attention and other thinking skills in adults with schizophrenia.
Who is behind this study?
The study sponsor is Amarantus BioScience Holdings, Inc.
Did this study involve medication?
Yes. The study involved medication, including Eltoprazine and Placebo.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
